These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4878094)

  • 21. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin.
    Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H
    Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of labeled insulin for a study of insulin antibodies. II. Study of antibodies in a patient with resistance to insulin].
    Foit R; Sieberová R; Kraml J; Prokes J; Zikmund E
    Vnitr Lek; 1968 Jun; 14(6):530-8. PubMed ID: 5661807
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunologic response to mono-component insulin in newly diagnosed diabetic patients.
    Devlin JG; Parameswaran V
    Ir Med J; 1975 Jun; 68(12):301-5. PubMed ID: 1140940
    [No Abstract]   [Full Text] [Related]  

  • 24. [Polystyrene latex used in the detection of insulin antibodies in blood of diabetics].
    Udolf E; Kośmiderski S; Grondal W
    Pol Tyg Lek; 1974 Nov; 29(47):2021-2. PubMed ID: 4473766
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diabetes mellitus with excessive insulin requirement].
    Berglund S
    Lakartidningen; 1968 Apr; 65(14):1400-4. PubMed ID: 5742584
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical problems of antibody formation in insulin therapy].
    Nakagawa M
    Horumon To Rinsho; 1972 May; 20(5):353-6. PubMed ID: 4560269
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determination of insulin antibody and its significance--with special reference to insulin antibody determination by the antibody binding method and the complement consumption method and fluorescent antibody technic].
    Onoe K; Kobashi K; Fujinaka S
    Nihon Rinsho; 1966 Apr; 24(4):753-68. PubMed ID: 5338258
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunological plasma insulin and obesity.
    Ahuja MM; Umashankar P
    J Assoc Physicians India; 1968 Apr; 16(4):229-31. PubMed ID: 5655888
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulin antibody production studied quantitatively with a modified radioimmunoassay technique and with radioimmunoelectrophoresis in patients treated with monocomponent (MC) insulin.
    Bruni B; Ricci C; Giolitti A; Osenda M; D'Alberto M; Turco GL
    J Nucl Biol Med; 1973; 17(3):123. PubMed ID: 4746315
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship of serum insulin to blood glucose: evidence of a defect during glucose tolerance in genetic prediabetic subjects.
    Soeldner JS; Gleason RE; Williams RF; Garcia MJ; Marble A
    Vox Sang; 1967 Jul; 13(1):35-7. PubMed ID: 6035814
    [No Abstract]   [Full Text] [Related]  

  • 31. Extraction of plasma insulin in radioimmunoassay for removal of nonspecific inhibitor and of circulating insulin antibody.
    Oneda A; Toyota T; Sato S; Yamagata S
    Tohoku J Exp Med; 1970 Jan; 100(1):75-84. PubMed ID: 5461274
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunologic problems of diabetes mellitus].
    Carta Q; Bumma C; Lanfranco G
    Minerva Med; 1974 Jan; 65(1):60-4. PubMed ID: 4425182
    [No Abstract]   [Full Text] [Related]  

  • 33. Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
    Fineberg SK
    Geriatrics; 1968 Sep; 23(9):137-46. PubMed ID: 5673663
    [No Abstract]   [Full Text] [Related]  

  • 34. Investigation of anti-insulin antibodies by the radiochemical ethanol precipitation method.
    Fratino P; Gastaldi F
    Boll Soc Ital Biol Sper; 1976 Jul; 52(13):1004-8. PubMed ID: 1088079
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetes mellitus and immunity.
    Mincu I; Cheţa D
    Med Interne; 1983; 21(4):257-66. PubMed ID: 6361973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of monocomponent insulin serum anti-insulin antibody levels (author's transl)].
    García de los Ríos M; Mella I; Durruty P; Ruiz F; López G; Tapia JC; González G
    Rev Med Chil; 1981 Jun; 109(6):509-15. PubMed ID: 7036310
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunologic tolerance against insulin. A therapeutic goal to prevent immunological complications in the diabetic patient using insulin].
    Jansen FK
    Med Welt; 1972 Nov; 23(48):1818-9. PubMed ID: 4654716
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients.
    Emanuelli G; Gatti G; Calcamuggi G; Anfossi G; Cotto A; Marcarino C; Camussi G; Ottone G
    Panminerva Med; 1981; 23(2):81-8. PubMed ID: 7033894
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the determination of insulin antibodies].
    Mikhkla SK; Ivanova TS
    Probl Endokrinol Gormonoter; 1966; 12(2):63-8. PubMed ID: 4972241
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of insulin antibodies in insulin treated patients.
    Giampietro O; Giannessi D; Del Chicca MG; Luche AD; Zucchelli GC; Navalesi R
    J Nucl Med Allied Sci; 1980; 24(3-4):153-8. PubMed ID: 7019394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.